RG
DCPH

Redmile Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,296,643
Closed -$83.3M 77
2024
Q1
$83.3M Buy
5,296,643
+495,103
+10% +$7.79M 3.06% 7
2023
Q4
$77.4M Buy
4,801,540
+326,156
+7% +$5.26M 2.77% 7
2023
Q3
$56.9M Sell
4,475,384
-403,182
-8% -$5.13M 2.71% 8
2023
Q2
$68.7M Sell
4,878,566
-703,539
-13% -$9.91M 2.64% 7
2023
Q1
$86.2M Buy
5,582,105
+1,988,788
+55% +$30.7M 3.74% 4
2022
Q4
$58.9M Buy
3,593,317
+620,288
+21% +$10.2M 2.41% 13
2022
Q3
$55M Buy
2,973,029
+1,542,112
+108% +$28.5M 2.13% 15
2022
Q2
$18.8M Buy
1,430,917
+766,100
+115% +$10.1M 0.72% 37
2022
Q1
$6.16M Hold
664,817
0.19% 58
2021
Q4
$6.5M Sell
664,817
-3,366,704
-84% -$32.9M 0.15% 62
2021
Q3
$137M Sell
4,031,521
-213,200
-5% -$7.24M 2.39% 14
2021
Q2
$155M Sell
4,244,721
-106,923
-2% -$3.91M 2.3% 11
2021
Q1
$195M Sell
4,351,644
-86,324
-2% -$3.87M 2.75% 7
2020
Q4
$253M Sell
4,437,968
-336,950
-7% -$19.2M 3.07% 8
2020
Q3
$245M Sell
4,774,918
-204,023
-4% -$10.5M 4.5% 6
2020
Q2
$297M Sell
4,978,941
-137,322
-3% -$8.2M 5.49% 3
2020
Q1
$211M Buy
5,116,263
+406,765
+9% +$16.7M 5.91% 3
2019
Q4
$293M Sell
4,709,498
-71,400
-1% -$4.44M 7.01% 1
2019
Q3
$162M Buy
4,780,898
+2,557,522
+115% +$86.8M 5.43% 4
2019
Q2
$50.1M Buy
2,223,376
+594,723
+37% +$13.4M 1.42% 24
2019
Q1
$37.8M Sell
1,628,653
-24,527
-1% -$569K 1.11% 30
2018
Q4
$34.7M Buy
1,653,180
+176,600
+12% +$3.71M 1.4% 27
2018
Q3
$57.2M Sell
1,476,580
-500
-0% -$19.4K 1.76% 20
2018
Q2
$58.1M Buy
1,477,080
+655,800
+80% +$25.8M 1.97% 18
2018
Q1
$16.5M Buy
821,280
+137,400
+20% +$2.75M 0.64% 44
2017
Q4
$14.7M Sell
683,880
-39,000
-5% -$836K 0.64% 47
2017
Q3
$12M Buy
+722,880
New +$12M 0.59% 44